Published online Sep 18, 2024. doi: 10.13105/wjma.v12.i3.97210
Revised: August 7, 2024
Accepted: August 14, 2024
Published online: September 18, 2024
Processing time: 110 Days and 19.2 Hours
Intestinal ultrasound (IUS) is an emerging, non-invasive, and highly sensitive diagnostic tool in inflammatory bowel disease (IBD), including ulcerative colitis (UC). Despite its potential, its adoption in clinical practice is limited due to a lack of standardization and awareness.
To perform a comprehensive scoping review based on a systematic literature review on IUS in UC to inform current practice.
Ninety-nine original articles about ultrasonography in UC were identified among 7608 citations searching PubMed and EMBASE databases for systematic review.
IUS can be useful as an initial diagnostic strategy in patients with suspected IBD/UC. In UC, IUS can predict endoscopic response, histologic healing, and steroid responsiveness in acute severe cases. IUS can predict response to biologics/small molecules (as early as 2 wk). IUS correlates well with ileo-colonoscopy, but IUS could miss rectal, jejunal, and upper GI lesions in suspected IBD and colon polyps or extra-intestinal manifestations in known IBD. IUS is useful in special situations (children, pregnancy, and postoperative Crohn's disease). Inter-observer agreement is acceptable and trained physicians have comparable diagnostic accuracy. Point-of-care ultrasound impacted management in 40%-60% of cases. Hand-held IUS has excellent agreement with conventional IUS.
IUS is a non-invasive, highly sensitive tool in the diagnosis and monitoring of UC, offering excellent patient satisfaction. Point-of-care ultrasound by IBD physicians can significantly impact clinical decision-making.
Core Tip: Intestinal ultrasound (IUS) is an emerging non-invasive diagnostic tool for ulcerative colitis (UC) with high sensitivity. This scoping review demonstrates IUS's effectiveness in predicting endoscopic response, histologic healing, and steroid responsiveness in UC, as well as its role in early prediction of biologic response. While IUS may not detect all lesions, it shows excellent agreement with ileo-colonoscopy and is valuable in special situations like pregnancy and pediatric cases. Hand-held IUS matches conventional IUS in accuracy. Point-of-care IUS by inflammatory bowel disease physicians can significantly influence clinical decisions, underscoring its potential for broader clinical adoption.